OneMedNet (NASDAQ:ONMD) CFO Robert Lawrence Golden Sells 3,000 Shares of Company Stock

OneMedNet Corporation (NASDAQ:ONMD) CFO Robert Lawrence Golden sold 3,000 shares of the business’s stock in a transaction dated Tuesday, September 15th. The stock was sold at an average price of $6.30, for a total value of $18,900.00. Following the transaction, the chief financial officer directly owned 94,291 shares of the company’s stock, valued at $594,033.30. The trade was a 3.08% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Robert Lawrence Golden also recently made the following trade(s):

• On Monday, September 21st, Robert Lawrence Golden sold 3,000 shares of OneMedNet stock. The shares were sold at an average price of $6.63, for a total transaction of $19,890.00.

OneMedNet Stock Performance

ONMD traded down $0.52 during trading on Friday, reaching $4.30. The stock had a trading volume of 24,653 shares, compared to its average volume of 69,105. The stock has a market cap of $25.50 million, a PE ratio of -2.69 and a beta of 1.14. The business has a 50-day moving average of $6.24 and a 200-day moving average of $7.32. OneMedNet Corporation has a one year low of $4.30 and a one year high of $42.20.

Analysts Set New Price Targets

Separately, Weiss Ratings upgraded OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, August 24th. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

OneMedNet Company Profile

OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.

The company’s technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository.